Hyponatremia screening: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Hyponatremia}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to the [guide...") |
|||
| (12 intermediate revisions by one other user not shown) | |||
| Line 2: | Line 2: | ||
{{Hyponatremia}} | {{Hyponatremia}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Saeedeh}} | ||
==Overview== | ==Overview== | ||
Hyponatremia is the most common electrolyte disturbances which are common with certain medical conditions and drugs. Screening the hyponatremia is necessary for preventing further decrease in serum sodium and complications of treatment. | |||
==Screening== | |||
Plasma sodium should be check in | |||
*1–2 weeks after initiation of [[Thiazides|thiazide]], [[Serotonin-norepinephrine reuptake inhibitor|SNRI]], and [[Selective serotonin reuptake inhibitor|SSRI]] therapy, especially in patients at high risk for hyponatremia <ref>{{Cite journal | |||
| author = [[T. J. Wilkinson]], [[E. J. Begg]], [[A. C. Winter]] & [[R. Sainsbury]] | |||
| title = Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people | |||
| journal = [[British journal of clinical pharmacology]] | |||
| volume = 47 | |||
| issue = 2 | |||
| pages = 211–217 | |||
| year = 1999 | |||
| month = February | |||
| pmid = 10190657 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[K. M. Chow]], [[C. C. Szeto]], [[T. Y.-H. Wong]], [[C. B. Leung]] & [[P. K.-T. Li]] | |||
== | |||
| title = Risk factors for thiazide-induced hyponatraemia | |||
| journal = [[QJM : monthly journal of the Association of Physicians]] | |||
| volume = 96 | |||
| issue = 12 | |||
| pages = 911–917 | |||
| year = 2003 | |||
| month = December | |||
| pmid = 14631057 | |||
}}</ref> | |||
*All hospitalized patients on admission | |||
*Check plasma level daily in all patients with hyponatremia | |||
*Check plasma level in all patients with risk of hyponatremia | |||
To see the risk factors for developing hyponatremia, click [[Hyponatremia risk factors#Risk factors|here]]. | |||
==References== | ==References== | ||
Latest revision as of 17:53, 7 July 2021
|
Hyponatremia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hyponatremia screening On the Web |
|
American Roentgen Ray Society Images of Hyponatremia screening |
|
Risk calculators and risk factors for Hyponatremia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Saeedeh Kowsarnia M.D.[2]
Overview
Hyponatremia is the most common electrolyte disturbances which are common with certain medical conditions and drugs. Screening the hyponatremia is necessary for preventing further decrease in serum sodium and complications of treatment.
Screening
Plasma sodium should be check in
- 1–2 weeks after initiation of thiazide, SNRI, and SSRI therapy, especially in patients at high risk for hyponatremia [1][2]
- All hospitalized patients on admission
- Check plasma level daily in all patients with hyponatremia
- Check plasma level in all patients with risk of hyponatremia
To see the risk factors for developing hyponatremia, click here.
References
- ↑ T. J. Wilkinson, E. J. Begg, A. C. Winter & R. Sainsbury (1999). "Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people". British journal of clinical pharmacology. 47 (2): 211–217. PMID 10190657. Unknown parameter
|month=ignored (help) - ↑ K. M. Chow, C. C. Szeto, T. Y.-H. Wong, C. B. Leung & P. K.-T. Li (2003). "Risk factors for thiazide-induced hyponatraemia". QJM : monthly journal of the Association of Physicians. 96 (12): 911–917. PMID 14631057. Unknown parameter
|month=ignored (help)